Table IV.
Univariate logistic regression model analysis of mortality related factors in patients with RPH
Variable | Total | No mortality | Mortality | Odds ratio | 95% CI | P-value | |
---|---|---|---|---|---|---|---|
Age (≥ 65 years) | 36 | 25 (69.44%) | 11 (30.55%) | 4.255 | 0.059–0.938 | 0.04* | |
Male sex | 41 | 33 (80.5%) | 8 (19.5%) | 0.848 | 0.258–2.793 | 0.787 | |
LVEF < 55 | 23 | 17 (31.5%) | 6 (42.9%) | 1.632 | 0.490–5.443 | 0.425 | |
BMI (≥ 25 kg/m2) | 46 | 36 (78.2%) | 10 (21.7%) | 0.800 | 0.220–2.907 | 0.735 | |
HT | 33 | 26 (48.1%) | 7 (50%) | 0.929 | 0.287–3.009 | 0.902 | |
DM | 23 | 19 (35.2%) | 4 (28.6%) | 1.357 | 0.375–4.916 | 0.642 | |
CRF | 7 | 5 (71.4%) | 2 (28.6%) | 0.612 | 0.106–3.548 | 0.584 | |
AF | 5 | 3 (5.6%) | 2 (14.3%) | 0.353 | 0.053–2.351 | 0.282 | |
COPD | 11 | 5 (9.3%) | 6 (42.9%) | 7.352 | 0.033–0.553 | 0.005* | |
CVD | 6 | 5 (9.3%) | 1 (7.1%) | 1.327 | 0.142–12.366 | 0.804 | |
Localization of hematoma (right) | 37 | 28 (52.8%) | 9 (64.3%) | 0.622 | 0.184–2.105 | 0.446 | |
Mean hematocrit drop ≥ 15% | 34 | 24 (70.5%) | 10 (29.4%) | 0.320 | 0.089–1.148 | 0.080* | |
Highest creatinine ≥ 2 mg/dl (CRF patients were not included) | 23 | 11 (20.4%) | 12 (85.7%) | 23.255 | 0.008–0.219 | 0.001* | |
RBC transfusion ≥ 10 U | 9 | 2 (3.7%) | 7 (50%) | 26.315 | 0.007–0.223 | 0.001* | |
RPH diagnosis more than 24 h following CC | 47 | 34 (72.3%) | 13 (27.7%) | 0.131 | 0.016–1.076 | 0.059* | |
Pre-procedure medical treatment | IV heparin | 7 | 5 (71.4%) | 2 (28.6%) | 0.612 | 0.106–3.548 | 0.584 |
Clopidogrel | 41 | 33 (61.1%) | 7 (50%) | 1.571 | 0.482–5.124 | 0.454 | |
LMW heparin | 29 | 23 (42.6%) | 6 (42.9%) | 0.989 | 0.302–3.245 | 0.986 | |
Warfarin | 6 | 6 (11.1%) | 0 | 1.625 | 0.179–14.723 | 0.666 | |
ASA | 42 | 36 (66.7%) | 6 (42.9%) | 1.842 | 0.562–6.038 | 0.313 | |
PCI | 46 | 38 (70.4%) | 8 (57.1%) | 1.781 | 0.532–5.967 | 0.349 | |
Surgical treatment | 8 | 3 (37.5%) | 5 (62.5) | 9.433 | 0.021–0.523 | 0.006* |
LVEF – left ventricle ejection fraction, BMI – body mass index, HT – hypertension, DM – diabetes mellitus, CRF – chronic renal failure, AF – atrial fibrillation, COPD – chronic obstructive pulmonary disease, CVD – cerebrovascular disease, CC – cardiac catheterization, PCI – percutaneous coronary intervention, IV – intravenous, LMW – low molecular weight, ASA – acetylsalicylic acid.
Differences between the groups statistically significant p < 0.05.